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Abstract
Background:  Notch plays a wide-ranging role in controlling cell fate, differentiation and
development. The PI3K-Akt pathway is a similarly conserved signalling pathway which regulates
processes such as differentiation, proliferation and survival. Mice with disrupted Notch and PI3K
signalling show phenotypic similarities during haematopoietic cell development, suggesting
functional interaction between these pathways.
Results: We show that cellular responsiveness to Notch signals depends on the activity of the
PI3K-Akt pathway in cells as diverse as CHO cells, primary T-cells and hippocampal neurons.
Induction of the endogenous PI3K-Akt pathway in CHO cells (by the insulin pathway), in T-cells
(via TCR activation) or in neurons (via TrKB activation) potentiates Notch-dependent responses.
We propose that the PI3K-Akt pathway exerts its influence on Notch primarily via inhibition of
GSK3-beta, a kinase known to phosphorylate and regulate Notch signals.
Conclusion: The PI3K-Akt pathway acts as a "gain control" for Notch signal responses. Since
physiological levels of intracellular Notch are often low, coincidence with PI3K-activation may be
crucial for induction of Notch-dependent responses.
Background
The phosphoinositide-3-kinases (PI3Ks) constitute an
enzyme family of p85/p110 heterodimers responsible for
regulating numerous biological processes in diverse cell
types [1] such as cellular proliferation, differentiation and
survival. Of particular interest is the role of this pathway
in lymphocyte activation, where antigen and cytokine
receptor ligation result in activation of PI3K-driven signals
[2]. A key target of PI3K activity is Akt/PKB, which medi-
ates many of the effects of PI3K activation [3].
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PI3K is activated in T-cells both in response to T-cell recep-
tor (TCR) stimulation, and by engagement of the co-stim-
ulatory receptor CD28. Gene targeting studies have
emphasised the essential role PI3K plays in these
responses: whereas PI3K-deficient mice are immunodefi-
cient [4,5], constitutive activity is associated with hyper-
proliferative T-cell responses and autoimmunity [6].
Equally, preventing the termination of PI3K activity by
conditional gene targeting of the lipid phosphatase Pten
in T-cells leads to autoimmunity and development of lym-
phoma [7]. These studies demonstrate that PI3K activity is
tightly regulated and plays an integral role in the mainte-
nance of lymphocyte homeostasis.
The Notch signalling pathway plays a critical role in a
wide range of developmental processes in the embryo,
including binary lineage decisions and boundary forma-
tion [8]. Binding of the Notch ligands Delta or Jagged to
the Notch receptor instigates proteolytic cleavage which
releases the Notch intracellular domain (N-IC) [8] which
activates the transcription factor CBF-1 which, in turn,
controls target genes such as Hes-1 [9]. Central to Notch's
role is its ability to modulate the differentiative potential
of pluripotent cells, for instance in the neural stem cell
compartment. The effects of Notch also extend to the
developing immune system, where it directs the differen-
tiation of lymphoid precursors [10]. Recent data have
highlighted unexpected functions for the Notch pathway
in regulating cells of the peripheral immune system. Co-
incident delivery of Notch signals to T-cells exerts a pro-
found effect upon the outcome of antigen-stimulation in
vitro [11-13] suggesting that interplay between the antigen
receptor and Notch pathways regulate the outcome of
peripheral T-cell responses.
Mice expressing catalytically inactive PI3K subunit p110δ
[5] or a deletion of p110δ [4] exhibit defective B-cell and
T-cell receptor signalling: antigen-mediated activation of
BCR or TCR fails to activate Akt and cells exhibit defective
proliferation and cytokine responses. Recent publications
have demonstrated that Notch signals modulate cytokine
production by T-cells [12,13], suggesting that the Notch
pathway integrates with TCR-mediated signals to modu-
late cytokine production. Furthermore, marginal zone B
(MZB) cell development is severely impaired in both
p110δ- and Notch2-deficient mice [4,14]. Taken together
with Notch's ability to modulate TCR signals, this pheno-
typic similarity suggested to us the possibility of Notch/
PI3K signalling integration. Our studies reveal that the
PI3K-Akt pathway is a potent inducer of Notch-dependent
responses in cell types as diverse T-cells and neurons,
demonstrating that this is a cell signalling paradigm with
broad applicability.
Results
Inhibition of the PI3K-Akt pathway impairs Notch 
signalling in Jurkat T-cells
To address whether the PI3K pathway is a regulator of
Notch-responsiveness, we generated a Jurkat E6.1 T-cell
line which stably expresses full-length human Notch2
cDNA (J-N2 cells). J-N2 cells were treated with plate-
bound recombinant human Delta1 protein (hereafter
referred to as Delta1-Fc) fusion protein, and Notch signal-
ling was measured using a transiently-transfected CBF1-
driven luciferase reporter construct (p10xCBF1-luc).
Plate-bound recombinant Delta1-Fc efficiently transacti-
vated CBF1-luc, driving around a 10-fold increase in activ-
ity (Fig. 1A). A similar result was obtained using the
murine Hes-1 promoter cloned upstream of the luciferase
reporter (data not shown). Strikingly, treatment of these
cells with the PI3K inhibitor LY294002 led to a dose-
dependent decrease in Delta1-Fc-induced Notch signal-
ling (Fig. 1A). A similar result was observed with the
mechanistically-distinct PI3K inhibitor Wortmannin
(data not shown). The integrity of this reporter assay as an
accurate reflection of Notch signalling was confirmed by
assessing mRNA levels of the Notch target gene Hes-1 by
Q-PCR in Delta1-Fc-treated J-N2 cells (Fig. 1B). As with
the CBF1-dependent reporter, treatment with LY294002
inhibited the up-regulation of Hes-1 by Delta1-Fc.
The lipid phosphatase Pten dephosphorylates the 3' phos-
phoinositide products of PI3K catalysis and prevents
downstream PI3K signaling [1]. Jurkat E6.1 cells are defi-
cient in expression of Pten, and therefore have a highly
active PI3K-Akt pathway [15]. We therefore hypothesised
that reconstituting this enzyme would reduce Notch sig-
nalling. Transient expression of Pten in J-N2 cells led to a
decrease in both basal and Notch ligand-induced activa-
tion of CBF1-dependent gene expression (Fig. 1C). Pten-
transfected and control cells showed equivalent CBF1-
reporter activity in the presence of LY294002, demonstrat-
ing that once PI3K activity is abolished pharmacologi-
cally, Pten over-expression becomes redundant.
The PI3K pathway activates several enzymes, including
the central signalling molecule Akt/PKB. To further define
the mechanism by which PI3K activity regulates Notch
signals, we asked whether the inhibitory effect of
LY294002 could be recapitulated with an inhibitor of Akt.
Blocking Akt activity in J-N2 cells with the selective inhib-
itor SH-6 [16] inhibited Delta1-Fc-mediated upregulation
of Notch signalling (Fig. 1D). Taken together, these data
identify the PI3K-Akt pathway as being responsible for the
high level of ligand-induced Notch activation in J-N2
cells.BMC Cell Biology 2006, 7:10 http://www.biomedcentral.com/1471-2121/7/10
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Inhibition of the PI3K-Akt pathway impairs Notch signalling in Jurkat T-cells Figure 1
Inhibition of the PI3K-Akt pathway impairs Notch signalling in Jurkat T-cells. (A) J-N2 cells were transfected with 
14 µg of p10xCBF1-luc and 1 µg pTK-RL, incubated overnight, then plated onto 96-well plates coated with either 20 µg/ml 
hIgG4 or 20 µg/ml hDelta1-Fc along with LY294002 for 6 hours. CBF1-reporter gene activity is normalised to Renilla control 
in this and all luciferase assays. (B) J-N2 cells were plated onto either hIgG4 or Delta1-Fc ± 10 µM LY294002, and incubated 
for 8 hours before being processed for Hes1 mRNA levels by Q-PCR (Hes1/18 rRNA). (C) J-N2 cells were transfected with 
10 µg of pCBF1x10-luc, 4 µg of Pten expression construct or empty pcDNA3.1 vector,1 µg of pTK-RL, and treated with either 
20 µg/ml hIgG4 or 20 µg/ml hDelta1-Fc ± 10 µM LY294002. CBF1-reporter activity was measured after 6 hr. All data is pre-
sented as mean ± s.d., and is representative of three repeat experiments. (D) J-N2 cells were transfected with p10xCBF1-luc 
and pTK-RL and stimulated as described in Fig. 1A, except that cells were treated with Akt inhibitor SH-6 (50 µM) or DMSO 
vehicle for 6 hours.BMC Cell Biology 2006, 7:10 http://www.biomedcentral.com/1471-2121/7/10
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The PI3K-Akt pathway regulates Notch-responsiveness in 
primary human CD4+ T-cells
We next investigated whether PI3K activity also regulates
Notch-responsiveness in primary human CD4+ T-cells. We
asked whether PI3K induction, triggered by TCR activa-
tion, could influence Hes-1 levels (Fig. 2A). In the absence
of any exogenously added Delta 1 (open bars-IgG con-
trol), TCR activation (with anti-CD3/anti-CD28 antibod-
ies) up-regulated Hes-1 levels in a LY294002-sensitive
manner. Significantly, this induction was also blocked by
the gamma secretase inhibitor DAPT, consistent with an
absolute requirement for N-IC. We also studied the induc-
tion of Hes-1 by Delta 1-Fc treatment (closed bars). In the
absence of TCR activation, Delta 1-Fc induced a small, but
consistent induction of Hes-1. However, coincidence of
Delta 1-Fc with TCR activation (anti-CD3/anti-CD28 anti-
bodies) dramatically up-regulated Hes-1 levels in a
LY294002-sensitive manner. Again, this induction was
also blocked by the gamma secretase inhibitor DAPT.
LY294002 also inhibited Notch signalling in primary
human CD4+ T-cells transfected with p10xCBF1-luc and a
Notch1 intracellular domain expression plasmid (data
not shown), demonstrating that the effect of PI3K on
Notch is exerted downstream of Notch cleavage. Thus,
TCR activation dramatically increases the cellular
response to Notch signals in primary human T cells via a
mechanism requiring the PI3K-Akt pathway.
We then tested whether Akt activation is sufficient to
boost Notch-responsiveness in human T cells. Over-
expression of a constitutively-active Akt construct (gagAkt
[17]) was sufficient to potentiate the ability of pN1-IC to
drive CBF1-dependent reporter activity (Fig. 2B).
PI3K regulates Notch signals through GSK3β activity
Previous data has suggested that inactivation of GSK3β by
the Wingless pathway enhanced Notch signals by prevent-
ing inhibitory phosphorylation of N-IC by GSK3β [18].
Therefore, given that Akt phoshorylates and inactivates
GSK3β [19], we hypothesised that Akt-dependent inacti-
vation of GSK3β might be responsible for Notch potenti-
ation. To address this question, we looked at the N1-IC-
induced Notch response in primary human CD4+ T-cells
treated with the GSK3β inhibitor lithium chloride.
Increasing concentrations of LiCl induced a dramatic
increase in Notch signalling (Fig. 3A).
In contrast to N1-IC overexpression, triggering Notch sig-
nalling using recombinant ligand to ligate endogenous
full length Notch generates far weaker signalling. This fact,
coupled with limited transfection efficiency of primary T
cells, makes it technically difficult to achieve robust
induction of a transfected CBF1 reporter construct by
Delta1-Fc. However, given the large potentiation of
Notch-responsiveness by LiCl (Fig. 3A), we hypothesised
that, in the presence of LiCl, robust Delta1-Fc dependent
induction of a CBF1 reporter could be observed. We
found that, consistent with the technical issues outline
above, plate-bound Delta1-Fc activates the CBF1 reporter
weakly and unreliably in the absence of LiCl (Fig. 3B).
However, LiCl greatly potentiates activation of the
reporter by plate-bound Delta1-Fc (Fig. 3B). Thus, the
GSK3β inhibitor LiCl is sufficient to potentiate primary
Notch-responsiveness in primary human CD4+ T-cells,
triggered either by N1-IC expression, or by ligation of
endogenous full length Notch by plate-bound ligand.
In Jurkat T-cells, deficient in Pten expression, basal Akt
activity is high [15], so we expected GSK3β to be maxi-
mally inhibited. Consistent with this, LiCl treatment did
not exert any further effect on Delta1-induced signalling
in Jurkat-N2 cells (Fig. 3C).
PI3K activity also regulates Notch responsiveness in CHO 
cells and neurons
To investigate whether PI3K-dependent regulation of
Notch responsiveness may be a general phenomenon
extending beyond T-cell biology, we took advantage of a
Notch-dependent CHO cell reporter assay which we have
previously described [20]. In this assay, CHO cells which
stably express a human Notch2 receptor cDNA and a
CBF1-dependent luciferase reporter construct (termed
CHO-N2) are co-cultured with a second CHO cell line
which stably expresses the full-length human Delta1
cDNA (termed CHO-hDelta1). CHO-hDelta1 cells trigger
a dose-dependent luciferase response to the CHO-N2
cells, whilst control CHO parental cells fail to activate the
Notch pathway (Fig. 4A). We next asked if activation of
the PI3K pathway influenced Notch signals in this assay
system. As predicted from our T-cell studies, including
insulin in the culture medium potentiated Notch signal-
ling, and this effect was blocked almost completely by
inclusion of LY294002 (Fig. 4B). From our observations
with T-cells, we hypothesisesd that GSK3β inhibition with
LiCl could substitute for insulin in potentiating Notch sig-
nalling induced by CHO-hDelta1 cells. LiCl does indeed
potentiate Notch signalling in the CHO co-culture system,
leading to a substantial enhancement of ligand-depend-
ent reporter activity (Fig. 4C).
We then extended our study further, this time into pri-
mary neurons, cell types where Notch plays an emerging
role in processes such as dendritic patterning and synaptic
plasticity [21,22]. As observed with T-cells, inhibition of
GSK3β with lithium chloride strongly enhanced the level
of Notch signalling in rat primary hippocampal neurons
in a dose-dependent manner (Fig. 4D). PI3K-activating
neurotrophins such as BDNF regulate cell survival, prolif-
eration and differentiation of both peripheral and central
neurons [23]. Strikingly, BDNF treatment potentiatedBMC Cell Biology 2006, 7:10 http://www.biomedcentral.com/1471-2121/7/10
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The PI3K-Akt pathway regulates Notch-responsiveness in primary human CD4+ T-cells Figure 2
The PI3K-Akt pathway regulates Notch-responsiveness in primary human CD4+ T-cells. (A) 24-well tissue culture 
plates were coated with anti-human IgG4 and anti-mouse IgG2a capture antibodies at 1 µg/ml in PBS, and incubated at 4°C, 
overnight. Appropriate stimuli added: Delta1-Fc or hIgG4 as control, both at 20 µg/ml in PBS and anti-CD3 (Hit3a, IgG2a) or 
mIgG as control, both at 1 µg/ml in PBS, and incubated at 37°C, 3 h. Plates were washed with PBS and positively selected 
hCD4+ T-cells were seeded at 2 × 106 cells/well, in 1 ml of media to a total of 1 × 107 cells/stimulation. Cells were stimulated 
overnight ± 10 µM DAPT or 10 µM LY294002 and 2 µg/ml anti-CD28 where applicable. Cells were pooled, RNA prepared and 
cDNA synthesised as described in Methods. Relative Hes1 expression was determined by Q-PCR. Data shown represents trip-
licate assays of cDNA prepared from pooled cells, and is representative of two individual experiments performed using CD4+ 
T-cells prepared from different donors.(B) Human primary CD4+ T-cells were nucleofected with 4 µg p10xCBF-luc, 0.5 µg 
pTK-RL and 1 µg of either pN1-IC or empty pcDNA3.1, and 2 µg of either gagAkt or kinase-dead (KD) Akt construct. CBF1-
reporter activity is presented as mean normalised luminescence ± s.d. Data representative of two repeat experiments from dif-
ferent blood donors.BMC Cell Biology 2006, 7:10 http://www.biomedcentral.com/1471-2121/7/10
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pN1-IC-driven reporter activity, and this was abrogated by
treatment with LY294002 (Fig. 4D). Pten  transfection
ablated both basal and BDNF-stimulated reporter signal-
ling, further underlining the role of the PI3K pathway in
promoting Notch-responsiveness in neurons. Moreover,
over-expression of constitutively active gagAkt was suffi-
cient to potentiate pN1-IC-driven reporter activity (Fig.
4E). To further reinforce this finding, expression of a con-
stitutively-active GSK3β construct (S9A), which is resist-
ant to inactivation by Akt, prevented BDNF induction of
Notch responsiveness (Fig. 4E). In contrast, expression of
wild-type GSK3β, which is inhibited by Akt activity, failed
to significantly reduce reporter activity. As observed with
T-cells, inhibition of GSK3β with lithium chloride
strongly enhanced the level of Notch signalling in a dose-
dependent manner (Fig. 4D). Thus the PI3K-Akt pathway
positively regulates Notch signals via GSK3β in neurons as
well as T-cells, as summarised in Fig. 5.
Discussion
The dynamic and interactive nature of intracellular com-
munication dictates that cells are in receipt of multiple
environmental signals at any given time. The cellular out-
put must represent a net response to a diverse set of cues,
and therefore the pathways mediating these responses are
frequently integrated. Our studies demonstrate for the
first time that PI3K activity strongly potentiates Notch
responsiveness in diverse cell types. Given the vital nature
of PI3K and Notch in controlling cellular survival and dif-
ferentiation, the implications of this finding are far-reach-
ing.
Reciprocal signalling between the Notch and PI3K 
pathways in T cells
Ligation of lymphocyte antigen receptors leads to activa-
tion of PI3K, initiating a diverse and wide-ranging set of
signalling pathways [2]. Our findings that PI3K activation
enhances Notch signalling leads us to suggest that Notch
pathway activation might be an inherent consequence of
lymphocyte activation. This positions the Notch pathway
as a central mediator of antigen-dependent stimulation of
immune cells.
T-cells are entirely quiescent in the absence of antigen sig-
nals, but are shifted rapidly into a state of activation fol-
lowing TCR ligation. Inappropriate control of this
activation can lead to autoimmune disease, and therefore
negative feedback loops are an inherent feature of T-cell
biology. Recent data show that Notch signals block Akt
activation in peripheral CD4+ T-cells [13]. Indeed we also
observe that in primary human CD4+ T-cells recombinant
Delta1-IgG4 fusion protein, or Notch-IC expression,
blocks TCR-mediated phosphorylation of Akt and GSK3β
(GM, BC, unpublished data). Although Akt activation is
essential for production of cytokines such as IL2 and IFNγ
by T-cells [24], constitutive activity is associated with cel-
lular transformation [25], and therefore the existence of a
negative feedback loop to limit antigen-dependent Akt
activation would appear rational. We have shown that co-
incident Notch signals are enhanced upon TCR activation,
and we hypothesise that by inhibiting Akt activity,
enhanced Notch signalling may constitute a negative feed-
back control impacting upon peripheral T-cell activation.
It is interesting to note that whilst the model we propose
is consistent with the data generated in peripheral T-cells,
a number of studies suggest that the opposite is true [26-
28]. Ciofani et al demonstrate that during the earliest
stages of T-cell development in the thymus Notch signals
co-operate with pre-TCR signalling to activate Akt-depend-
ent metabolism, thereby promoting expansion of those T-
cells which have undergone favourable TCR rearrange-
ment. The functional outcome of PI3K/Notch pathway
interaction thus appears to reverse from developing to
mature T-cells, an observation which further underlines
the ability of the Notch pathway to perform multiple, con-
text-dependent, tasks during development. We suggest
that a molecular understanding of how Notch can func-
tion as a bi-directional regulator of Akt activity is a
research priority.
PI3K and Wnt signalling modulate Notch responses via a 
common pathway
Our data strongly suggests that PI3K activity links to the
Notch signalling pathway through Akt-mediated inactiva-
tion of GSK3β, a known downstream effector of Akt. In
support of this data, PI3K and GSK3β [18,28,29] have
both been identified as binding partners for N-IC in
immunoprecipitation studies. GSK3β has also previously
been positioned as a component of the downstream
Notch signalling pathway in lateral inhibition in Dro-
sophila [30]. Furthermore, GSK3β activity is inhibited
downstream of both the wingless and PI3K pathways, and
thus represents a convergent site for integration of extra-
cellular signals with the Notch pathway. Indeed, inhibit-
ing GSK3β activity by activating the wingless pathway
with Wnt-1 has been shown to enhance Notch-dependent
reporter activity in NIH-3T3 cells [18]. We note, however,
that although an interaction between GSK3β and Notch
seems conclusively proven, the functional consequences
of this interaction are not consistent between different
studies. Whilst our data agrees with that of Espinosa et al.
[18], that is that GSK3β activity inhibits Notch signalling,
data from the Nye laboratory in GSK3β-deficient murine
embryonic fibroblasts demonstrates that GSK3β phos-
phorylates and stabilises Notch-IC, leading to enhanced
signalling [29]. Although we have no definitive explana-
tion for these experimental differences, it is possible that,
as discussed above for thymocytes and T-cells, the effect ofBMC Cell Biology 2006, 7:10 http://www.biomedcentral.com/1471-2121/7/10
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GSK3b on Notch changes between embryonic and mature
tissues.
Notch signalling in neural cells
Notch's role during embryonic development is not to
directly program neuronal differentiation itself, but to
inhibit this cell fate choice in neighbouring cells during
the lateral inhibition process [8]. During neurogenesis,
this is achieved by Notch target genes blocking transcrip-
tion of pro-neural transcription factors such as MASH-1.
Interestingly, conditional deletion of Pten in neural pro-
genitors leads to dramatic alterations in brain architec-
ture, an observation which the authors attribute to
increased proliferation and self-renewal of neural stem
cell populations [31]. Given that the data presented here
establishes the Notch-suppressing capability of Pten,
deregulated renewal of progenitors in these mice may be
in part due to enhanced Notch signalling. This hypothesis
awaits testing.
Notch also plays an emerging role in differentiating neu-
rons by inhibiting dendritic outgrowth [21]. It is tempting
to speculate that Notch-dependent dendritic retraction,
reliant on neuron-neuron interactions, is augmented by
target-derived neurotrophic factors promoting PI3K sig-
nalling. In differentiated neurons, Notch contributes to
synaptic plasticity, learning and memory [22,32]. The
long-standing involvement of BDNF and other neuro-
trophins in synaptic plasticity raise the possibility that
PI3K-Notch interplay is at work in this scenario as well.
Conclusion
Our data demonstrates that the potentiation of Notch sig-
nalling by PI3K is conserved in ontologically-distinct cell
types, leading us to suggest that it represents a general
mechanism of signal integration linking two evolutionar-
ily-conserved pathways together. This apparently simple
observation has far-reaching implications regarding the
mechanisms by which stem cell self-renewal and differen-
tiation proceeds. It will be interesting to assess the rele-
vance of this finding in other signalling contexts, such as
tumour formation, where Notch and PI3K have important
roles.
Methods
Materials and plasmids
SH-6, lithium chloride, LY294002, Wortmannin and
BDNF were from Calbiochem. Human IgG4 was from
Sigma. Dual-Glo Luciferase assay system was from
Promega. pN1-IC was constructed by inserting nucle-
otides coding for the intracellular domain of human
Notch1 (amino acids 1758 to 2557) preceded by an initi-
ator ATG codon into the BamHI and EcoRI sites of
pcDNA3.1 (Invitrogen). pAdTATA-luc was constructed by
inserting the Adenoviral major late promoter TATA
sequence immediately 5' of the luciferase gene in plasmid
pGL3Basic (Promega). p10xCBF1-luc was constructed by
inserting 10 copies of the CBF1 binding site 5' of the
AdTATA box in pAdTATA-luc. pTK-Renilla was from
Promega. Human Pten expression construct was generated
by PCR amplification of full-length human Pten  from
CD4+ T-cell cDNA, and then cloned into the HindIII and
EcoRI sites of pcDNA3.1. Constitutively-active (gagAkt)
and kinase dead (Akt-KD) Akt expression constructs were
a kind gift from Dr. Julian Downward [17]. Wild-type
(WT) and constitutively-active (S9A) GSK3β constructs
were a kind gift from Dr. J. Sadoshima [33]. All plasmids
were prepared using the EndoFree maxiprep system (Qia-
gen).
Cell culture
Jurkat E6.1 cells and Jurkat-N2 cells were grown in
RPMI1640 (+10% v/v FBS, 2 mM L-glutamine). Primary
CD4+ T cells were isolated from freshly-collected donor
blood as follows. Peripheral blood mononuclear cells
were prepared by centrifugation over Ficoll-Paque, incu-
bated with anti-CD4-coated magnetic beads (Miltenyi
Biotec) and selected on LS positive selection columns
(Miltenyi Biotec). After purification, primary CD4+ T-cells
were cultured in RPMI1640 (supplemented with 10% v/v
FBS, 2 mM L-glutamine and 5 × 10-6M β-mercaptoetha-
nol). CHO-N2 and CHO-Delta1 cells have been described
previously [20] and were routinely cultured in DMEM
(+10% v/v/FBS, 2 mM L-glutamine). Rat primary hippoc-
ampal neurons were isolated and cultured as described
[34], except growth media was supplemented with B27
(Gibco/BRL).
Transfections and reporter assays
Jurkat E6.1 cells and Jurkat-N2 cells were transfected using
Lipofectamine 2000 (Invitrogen). Cells were left 24 h
post-transfection, washed, counted and re-plated in tripli-
cate at 2 × 105 cells/well into flat-bottomed 96-well plates
which had been (where relevant) pre-coated o/n at 4°C
with hDelta1-Fc. Cells were stimulated, incubated o/n
and luciferase activity measured using the Dual-Glo sys-
tem (Promega). Firefly luciferase signal from the Notch-
dependent p10xCBF1-luc was normalised using the
Renilla luciferase signal driven by the pTK-Renilla.
Primary CD4+ T cells were transfected using the Amaxa
'nucleofection' system according to the manufacturer's
instructions. Briefly, 5 × 106 purified CD4+ T-cells were
resuspended in 100 µl of the appropriate Amaxa solution
and transfected with 5 µg plasmid DNA using Protocol U-
14. Cells were immediately transferred to 1 ml of pre-
warmed media, counted and plated as required. After
stimulation luciferase activity was detected using the
Dual-glo assay system (Promega).BMC Cell Biology 2006, 7:10 http://www.biomedcentral.com/1471-2121/7/10
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Inhibiting GSK3β with lithium chloride enhances Notch signals in primary human CD4+, but not Jurkat, T-cells Figure 3
Inhibiting GSK3β with lithium chloride enhances Notch signals in primary human CD4+, but not Jurkat, T-cells. 
(A) Primary human CD4+ T-cells were nucleofected with 4 µg p10xCBF-luc, 0.5 µg pTK-RL and 1 µg of either pN1-IC or 
pcDNA3.1 and plated o/n in triplicate with increasing concentrations of LiCl. Data is presented as the fold induction in normal-
ised luminescence compared to the untreated vector only control. (B) Primary human CD4+ T-cells were nucleofected with 4 
µg p10xCBF-luc and exposed to different levels of plate-bound Delta1-Fc in the presence or absence of LiCl (10 mM). (C) J-N2 
cells were transfected with p10xCBF1-luc and pTK-RL and stimulated overnight in increasing concentrations of LiCl. Data is 
presented as the fold induction in normalised luminescence compared to the untreated IgG4 control.BMC Cell Biology 2006, 7:10 http://www.biomedcentral.com/1471-2121/7/10
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The PI3k/GSK3β pathway also regulates Notch signalling in CHO cells and in primary neurons Figure 4
The PI3k/GSK3β pathway also regulates Notch signalling in CHO cells and in primary neurons. (A) CHO-N2 
cells were co-cultured with increasing numbers of either CHO-hDelta1 or control CHO cells and luciferase reporter activity 
assayed for after 24 hours. CBF1-dependent reporter activity is presented as the fold induction in luminescence versus CHO-
N2 cell only value. Mean ± sem given. (B) CHO-N2 cells were co-cultured with 104 CHO-hDelta1 cells per well ± insulin ± 
LY294002 as indicated. CBF1-reporter activity is presented as fold induction of non-insulin stimulated cells. (C) CHO-N2 cells 
were co-cultured with increasing numbers of CHO-hDelta1 in the presence or absence of LiCl (10 mM). (D) Rat primary hip-
pocampal neurons were transfected with 0.5 µg of p10xCBF1-luc and 0.05 µg pTK-RL, then stimulated overnight with either 
LiCl or 25 ng/ml BDNF ± 10 µM LY294002. (E) Neurons were transfected with 0.2 µg of p10xCBF1-luc, 0.05 µg pTK-RL, 0.05 
µg of pN1-IC and 0.4 µg of the relevant expression plasmid. CBF1-reporter activity is presented as normalised luminescence ± 
s.e.m (n = 3).(*p < 0.05, Mann Whitney U test).BMC Cell Biology 2006, 7:10 http://www.biomedcentral.com/1471-2121/7/10
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For neuronal experiments, rat primary hippocampal neu-
rons were transfected after 9 days in culture using Lipo-
fectamine 2000 and stimulated 36-48 hours later. Dual-
Glo Luciferase assays were performed following o/n stim-
ulation.
Generation of Delta fusion protein (Delta1-Fc)
A fusion protein comprising the extracellular domain of
human Delta1 fused to the Fc domain of human IgG4 was
prepared by inserting a nucleotide sequence coding for
the extracellular domain of human Delta1 (amino acids 1
to 537) into the expression vector pCON© (Lonza Biolog-
ics). This plasmid was expressed in CHO cells, purified by
affinity chromatography on ProteinA-Sepharose (Amer-
sham Biosciences) before concentration and buffer
exchange into PBS. Batch activity of this protein was con-
firmed as previously described [35].
Delta1-Fc capture and immobilisation onto tissue culture 
plastic
To assess the effect of isolated Delta1-Fc signalling on Jur-
kat-N2 and CD4+ T-cells, 96- or 24-well plates were
coated overnight at 4°C with anti-hIgG4 (1 µg/ml, BD
Biosciences). Plates were washed with PBS and incubated
for 2 hours at 37°C with 20 µg/ml Delta1-Fc or hIgG4
control, washed once again with PBS, before cells were
plated for stimulation.
To examine the effect of coincident Delta1-Fc and T-cell
receptor signalling on primary CD4+ T-cells, 96- or 24-
well plates were first coated overnight at 4°C with a mix-
ture of capture antibodies consisting of anti-mouse IgG2a
(1 µg/ml, BD Biosciences) and anti-hIgG4 (1 µg/ml, BD
Biosciences). Plates were washed with PBS and incubated
2 hours at 37°C with a mixture of anti-CD3 (3 µg/ml,
clone Hit3a, BD Biosciences) and 20 µg/ml Delta1-Fc or
hIgG4 control (Sigma). Plates were again washed with PBS
and purified CD4+ T cells were seeded at 2 × 105/well in
the presence of soluble anti-CD28 (2 µg/ml, clone
CD28.2, BD Bioscience).
Inter-cell Notch signalling assay
This assay has been described previously [20]. Briefly, a
CHO cell line (CHO-N2) was established which
expressed both a full-length human Notch2 cDNA, and
p10xCBF1-luc. 2 × 104 CHO-N2 cells were plated per well
into 96-well plates, and left to adhere for 2 hours. Notch
signalling was activated by plating an additional CHO
line which stably expresses full-length human Delta1
(CHO-hDelta1) onto the CHO-N2 cells. Cells were co-
cultured in this manner overnight, and luciferase activity
determined as described.
Reverse transcription and Quantitative PCR
RNA was isolated from cell samples using Rneasy kits
(Qiagen). First strand cDNA was synthesised with Super-
ScriptII (Invitrogen) oligo-d(T) and random decamers
(Invitrogen). Q-PCR was performed using SYBR green
detection chemistry on the Roche Lightcycler system.
Gene-specific quantification was achieved by comparing
each cDNA to a serially-diluted standard plasmid contain-
ing the relevant amplicon. Relative Hes-1 expression lev-
els were normalised to 18S rRNA housekeeping gene.
Primer sequences used were as follows (5' to 3'): 18S
rRNA, GTAACCCGTTGAACCCCATT and CCATC-
CAATCGGTAGTAGCG; Hes-1, CTCTCTTCCCTCCG-
GACTCT and GGCGCAATCCAATATGAAC.
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